Disclosure Plus

KESPION Decides on 13 Billion Won Third-Party Private Placement

Shin Ha-yeon
2026-08-18 15:05:19
[Edaily Reporter Shin Ha-yeon ] KESPION(079190)announced on the 18th that it has decided to conduct a third-party private placement worth approximately 13 billion won to raise operating funds.

Accordingly, 10,752,688 common shares will be issued at a price of 1,209 won per share, raising a total of 12.9999 billion won. The entire amount raised will be used as working capital. The payment date is September 14, and the new shares are scheduled to be listed on September 30.

The third-party allottee is the “Blue Materials, Parts, and Equipment New Technology Investment Fund No. 3.” The company stated that once the payment for this rights offering is completed, the investment fund will secure the position of largest shareholder. The newly issued shares will be subject to a one-year lock-up period.

Regarding the purpose of this capital increase, the company explained, “It is intended to achieve the company’s business objectives, such as maintaining its listing status and raising operating capital.”

Economy

Corporation

IT·Science

Economy

Samsung Electronics Forecasts Another Record Profit… All Eyes on HBM4 as Revenue Surpasses 100 Trillion

SamsungElectronics is expected to become the first South Korean company to enter the era of quarterly operating profit exceeding 100 trillion won. Buoyed by a boom in the memory semiconductor market d…
2026-10-05 16:55:03

Corporation

"The Era of 50,000 Convenience Stores"... Competing with Smart, Specialized Stores

The convenience store industry is expanding its network of specialty stores that focus on specific product categories for each company. With the number of convenience stores in South Korea exceeding 5…
2026-10-05 11:05:53

IT·Science

Samsung, SK, and Hanmi Emerge as Key Players in Asia-Pacific Pharmaceutical and Biotech “Big Deals”

(Graphic: ChatGPT) Three deals involving Korean companies were included among the top 10 influential transactions in the Asia-Pacific pharmaceutical and biotech market this year. SAMSUNG BIOLOGICS…
2026-10-05 17:19:01